BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 24996775)

  • 21. Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study.
    Mariusdottir E; Jonsson E; Marteinsson VT; Sigurdsson MI; Gudbjartsson T
    Scand J Urol; 2013 Dec; 47(6):476-82. PubMed ID: 23597159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma.
    Jeon HG; Choo SH; Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Eur J Cancer; 2014 Jan; 50(1):64-9. PubMed ID: 24060356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm.
    Roos FC; Brenner W; Jäger W; Albert C; Müller M; Thüroff JW; Hampel C
    BJU Int; 2011 Feb; 107(4):554-61. PubMed ID: 20707798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
    Jeldres C; Bensalah K; Capitanio U; Zini L; Perrotte P; Suardi N; Tostain J; Valeri A; Descotes JL; Rambeaud JJ; de La Taille A; Salomon L; Abbou C; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Jun; 103(12):1632-5. PubMed ID: 19545272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up.
    Janssen MWW; Linxweiler J; Terwey S; Rugge S; Ohlmann CH; Becker F; Thomas C; Neisius A; Thüroff JW; Siemer S; Stöckle M; Roos FC
    PLoS One; 2018; 13(5):e0196427. PubMed ID: 29723225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
    Kim EH; Jain S; Benway BM; Figenshau RS
    BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma.
    Schmid M; Abd-El-Barr AE; Gandaglia G; Sood A; Olugbade K; Ruhotina N; Sammon JD; Varda B; Chang SL; Kibel AS; Chun FK; Menon M; Fisch M; Trinh QD
    Urol Oncol; 2014 Nov; 32(8):1259-66. PubMed ID: 25129142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of tumor size on renal function and prediction of renal insufficiency after radical nephrectomy in patients with renal cell carcinoma.
    Ohno Y; Nakashima J; Ohori M; Hashimoto T; Iseki R; Hatano T; Tachibana M
    J Urol; 2011 Oct; 186(4):1242-6. PubMed ID: 21849191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological and functional outcomes after radical nephrectomy for renal cell carcinoma: a comprehensive analysis of prognostic factors.
    Sejima T; Iwamoto H; Masago T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
    Int J Urol; 2013 Apr; 20(4):382-9. PubMed ID: 23003206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
    Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
    Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
    von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
    Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Overall Survival Benefit for Patients with T1 Renal Cell Carcinoma after Nephron-Sparing Surgery Depends on Gender and Age.
    Liek E; Elsebach K; Göbel H; Krah X; Krautschick-Wilkens AW; Schweiger J; Steiner G; Steiner T; Wunderlich H
    Urol Int; 2018; 100(3):309-316. PubMed ID: 29502123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who really benefits from nephron-sparing surgery?
    Woldu SL; Weinberg AC; Korets R; Ghandour R; Danzig MR; RoyChoudhury A; Kalloo SD; Benson MC; DeCastro GJ; McKiernan JM
    Urology; 2014 Oct; 84(4):860-7. PubMed ID: 25260447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of rates and risk factors for development of anaemia and erythropoiesis-stimulating agent utilization after radical or partial nephrectomy.
    Woldrich J; Mehrazin R; Bazzi WM; Bagrodia A; Kopp RP; Malcolm JB; Kane CJ; Patterson AL; Wan JY; Derweesh IH
    BJU Int; 2012 Apr; 109(7):1019-25. PubMed ID: 21933323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.